RXST RxSight Inc

Price (delayed)

$48.67

Market cap

$1.81B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.25

Enterprise value

$1.78B

Highlights
RXST's gross profit has soared by 129% YoY and by 19% from the previous quarter
RxSight's debt has plunged by 94% YoY and by 16% from the previous quarter
RxSight's quick ratio has decreased by 28% YoY but it has increased by 14% from the previous quarter

Key stats

What are the main financial stats of RXST
Market
Shares outstanding
37.2M
Market cap
$1.81B
Enterprise value
$1.78B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
10.98
Price to sales (P/S)
17.74
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
17.6
Earnings
Revenue
$101.1M
EBIT
-$42.66M
EBITDA
-$38.28M
Free cash flow
-$39.17M
Per share
EPS
-$1.25
Free cash flow per share
-$1.06
Book value per share
$4.43
Revenue per share
$2.74
TBVPS
$4.97
Balance sheet
Total assets
$183.17M
Total liabilities
$19.24M
Debt
$2.52M
Equity
$163.93M
Working capital
$150.23M
Liquidity
Debt to equity
0.02
Current ratio
9.2
Quick ratio
8.05
Net debt/EBITDA
0.81
Margins
EBITDA margin
-37.9%
Gross margin
63.4%
Net margin
-44%
Operating margin
-47.1%
Efficiency
Return on assets
-24%
Return on equity
-27.7%
Return on invested capital
-26.8%
Return on capital employed
-25.9%
Return on sales
-42.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

RXST stock price

How has the RxSight stock price performed over time
Intraday
1.99%
1 week
-14.54%
1 month
-15.93%
1 year
49.98%
YTD
20.71%
QTD
-19.11%

Financial performance

How have RxSight's revenue and profit performed over time
Revenue
$101.1M
Gross profit
$64.09M
Operating income
-$47.66M
Net income
-$44.5M
Gross margin
63.4%
Net margin
-44%
RXST's gross profit has soared by 129% YoY and by 19% from the previous quarter
RXST's revenue has surged by 76% year-on-year and by 13% since the previous quarter
RxSight's net margin has soared by 59% YoY and by 19% from the previous quarter
The company's operating margin has surged by 55% YoY and by 16% QoQ

Growth

What is RxSight's growth rate over time

Valuation

What is RxSight stock price valuation
P/E
N/A
P/B
10.98
P/S
17.74
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
17.6
The EPS has grown by 43% year-on-year and by 11% since the previous quarter
RXST's P/B is 30% above its last 4 quarters average of 8.3
RXST's equity is up by 13% year-on-year and by 2.2% since the previous quarter
RXST's revenue has surged by 76% year-on-year and by 13% since the previous quarter
RXST's P/S is 11% above its last 4 quarters average of 15.6

Efficiency

How efficient is RxSight business performance
The return on sales has surged by 57% year-on-year and by 17% since the previous quarter
RXST's ROE has soared by 51% YoY and by 11% QoQ
The ROA has increased by 35% YoY and by 6% from the previous quarter
RxSight's return on invested capital has increased by 14% YoY but it has decreased by 7% QoQ

Dividends

What is RXST's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for RXST.

Financial health

How did RxSight financials performed over time
The company's total liabilities has shrunk by 67% YoY and by 13% QoQ
RxSight's quick ratio has decreased by 28% YoY but it has increased by 14% from the previous quarter
RxSight's debt is 98% less than its equity
RxSight's debt has plunged by 94% YoY and by 16% from the previous quarter
RXST's debt to equity has dropped by 94% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.